LexaGene Holdings Inc. (CVE:LXG – Get Free Report) was down 19.2% on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,375 shares were traded during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The firm has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The business has a 50 day moving average price of C$0.11 and a 200-day moving average price of C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Articles
- Five stocks we like better than LexaGene
- How to Invest in the FAANG Stocks
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- Overbought Stocks Explained: Should You Trade Them?
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is Insider Trading? What You Can Learn from Insider Trading
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
